<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Automating Process Development&amp;#160;Labs</title><link>/industries/lifesciences/b/life-sciences-blog/posts/automating-process-development-160-labs</link><description>For pharmaceutical and biotech manufacturers, the process of drug compound experimentation requires robust and reproducible results before the scale up process can begin. Emerson’s Chris Amstutz pointed me to a great whitepaper by Broadley James, Automating</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>